Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study - PubMed (original) (raw)
Clinical Trial
. 1988 Dec;15(12):1747-54.
Affiliations
- PMID: 14552308
Clinical Trial
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study
G Borg et al. J Rheumatol. 1988 Dec.
Abstract
The effect of early initiation of auranofin (AF) therapy on outcome measures was studied in a controlled 24-month double blind trial in 138 patients with early rheumatoid arthritis (RA) using an intent to treat approach. Patients were randomized to AF or placebo but in case of insufficient effect or intolerable adverse events, they switched to open disease modifying antirheumatic drug therapy. Patients who started AF fared significantly better in improved joint swelling. Stanford Health Assessment Questionnaire index, Keitel functional test, and mental depression, and furthermore, radiologic progression was significantly retarded. Our results support a disease modifying beneficial effect of AF in early active RA.se
Similar articles
- Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
Rao UR, Naidu MU, Kumar TR, Shobha U, Askar MA, Ahmed N, Sarada P, Venubabu K, Shantaram V, Menon GN, et al. Rao UR, et al. J Rheumatol. 1995 Jul;22(7):1235-40. J Rheumatol. 1995. PMID: 7562751 Clinical Trial. - Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial.
Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW. Lee EY, et al. Clin Ther. 2006 Dec;28(12):2052-60. doi: 10.1016/j.clinthera.2006.12.019. Clin Ther. 2006. PMID: 17296461 Clinical Trial. - Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
Furst DE, Lindsley H, Baethge B, Botstein GR, Caldwell J, Dietz F, Ettlinger R, Golden HE, McLaughlin GE, Moreland LW, Roberts WN, Rooney TW, Rothschild B, Sack M, Sebba AI, Weisman M, Welch KE, Yocum D. Furst DE, et al. Arthritis Rheum. 1999 Feb;42(2):357-65. doi: 10.1002/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J. Arthritis Rheum. 1999. PMID: 10025931 Clinical Trial. - [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
Nasonova VA, Lukina GV, Sigidin IaA, Badokin VV. Nasonova VA, et al. Ter Arkh. 2003;75(5):88-90. Ter Arkh. 2003. PMID: 12847908 Review. Russian. No abstract available. - Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.
Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J. Doyle MK, et al. Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Semin Arthritis Rheum. 2009. PMID: 18823645 Review.
Cited by
- Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis.
Guski LS, Jürgens G, Pedder H, Levinsen NKG, Andersen SE, Welton NJ, Graudal N. Guski LS, et al. JAMA Netw Open. 2023 Oct 2;6(10):e2335950. doi: 10.1001/jamanetworkopen.2023.35950. JAMA Netw Open. 2023. PMID: 37801318 Free PMC article. - Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.
Carlström KE, Ewing E, Granqvist M, Gyllenberg A, Aeinehband S, Enoksson SL, Checa A, Badam TVS, Huang J, Gomez-Cabrero D, Gustafsson M, Al Nimer F, Wheelock CE, Kockum I, Olsson T, Jagodic M, Piehl F. Carlström KE, et al. Nat Commun. 2019 Jul 12;10(1):3081. doi: 10.1038/s41467-019-11139-3. Nat Commun. 2019. PMID: 31300673 Free PMC article. - Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives.
Burgers LE, Raza K, van der Helm-van Mil AH. Burgers LE, et al. RMD Open. 2019 Apr 3;5(1):e000870. doi: 10.1136/rmdopen-2018-000870. eCollection 2019. RMD Open. 2019. PMID: 31168406 Free PMC article. Review. - The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.
Barhamain AS, Magliah RF, Shaheen MH, Munassar SF, Falemban AM, Alshareef MM, Almoallim HM. Barhamain AS, et al. Open Access Rheumatol. 2017 Jul 28;9:139-150. doi: 10.2147/OARRR.S138830. eCollection 2017. Open Access Rheumatol. 2017. PMID: 28814904 Free PMC article. Review. - Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells.
Kim NH, Park HJ, Oh MK, Kim IS. Kim NH, et al. BMB Rep. 2013 Jan;46(1):59-64. doi: 10.5483/bmbrep.2013.46.1.123. BMB Rep. 2013. PMID: 23351386 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical